PUBLISHER: The Business Research Company | PRODUCT CODE: 1947132
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947132
Single-cell transcriptomics is a powerful technique that enables the study of gene expression at the individual cell level. It helps identify cellular heterogeneity and unique transcriptional profiles within complex tissues. This approach allows researchers to uncover cellular diversity, discover rare cell types, trace developmental lineages, and gain deeper insights into disease mechanisms.
The main component types of single-cell transcriptomics include equipment, consumables, software, and services. In single-cell transcriptomics, equipment is used for precise RNA analysis at the individual cell level, advancing genomic research and personalized medicine. Various technologies, such as single-cell RNA sequencing, microfluidics-based techniques, and others, are employed for applications including clinical diagnostics, developmental biology, drug discovery, and more. These tools are used by a wide range of end-users, including academic and research institutions, hospitals and diagnostic centers, and pharmaceutical and biotechnology companies.
Tariffs are impacting the single-cell analysis transcriptomics market by increasing the cost of imported sequencing equipment, reagents, and microfluidics consumables. Segments such as RNA sequencers, library preparation kits, and microarray instruments are most impacted, particularly in Asia-Pacific regions like China and India that are major import hubs. This has led to higher operational costs and supply chain challenges. On the positive side, tariffs have encouraged local manufacturing, alternative sourcing strategies, and innovation in cost-effective technologies for transcriptomics research.
The single-cell analysis transcriptomics market research report is one of a series of new reports from The Business Research Company that provides single-cell analysis transcriptomics market statistics, including single-cell analysis transcriptomics industry global market size, regional shares, competitors with a single-cell analysis transcriptomics market share, detailed single-cell analysis transcriptomics market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell analysis transcriptomics industry. This single-cell analysis transcriptomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The single-cell analysis transcriptomics market size has grown rapidly in recent years. It will grow from $1.08 billion in 2025 to $1.22 billion in 2026 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to high cost of early sequencing equipment, limited accessibility of microfluidics technologies, reliance on conventional bulk tissue analysis, growing academic research funding, emerging awareness of cellular heterogeneity.
The single-cell analysis transcriptomics market size is expected to see rapid growth in the next few years. It will grow to $1.92 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to technological advancements in single-cell sequencing platforms, integration of cloud-based bioinformatics solutions, rising investment by pharmaceutical and biotechnology companies, increased adoption in personalized medicine, expansion of hospital and diagnostic center applications. Major trends in the forecast period include increasing adoption of single-cell rna sequencing techniques, rising use of microfluidics-based platforms, expansion of clinical diagnostics applications, growth in drug discovery and development research, enhanced data analysis and bioinformatics capabilities.
The growing adoption of personalized medicine is expected to accelerate the expansion of the single-cell analysis transcriptomics market. Personalized medicine is a tailored approach to medical treatment based on an individual's genetic profile, lifestyle, and environmental factors. The rise in personalized medicine is driven by advances in genetic sequencing, which enable treatments customized to a patient's genetic makeup for enhanced effectiveness. Single-cell analysis transcriptomics plays a crucial role by uncovering gene expression profiles at the individual cell level, guiding the development of personalized treatments based on a patient's unique biology. This approach improves therapeutic outcomes, reduces side effects, and supports early disease diagnosis. For instance, in February 2024, the Personalized Medicine Coalition, a US-based healthcare organization, reported that the U.S. Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, a significant increase from the six approvals in 2022. This growing trend in personalized medicine is driving the growth of the single-cell analysis transcriptomics market.
Major companies operating in the single cell analysis transcriptomics market are focusing on developing innovative products, such as single cell RNA sequencing kits, to streamline workflows and enable deeper insights into cellular heterogeneity. A single cell RNA sequencing kit is a specialized tool to isolate and analyze gene expression at the individual cell level. It allows researchers to uncover cellular diversity and gain insights into complex biological processes. For instance, in January 2024, Scale Biosciences, a US based biotechnology company specializing in single cell solutions, launched the Single Cell RNA Kit v1.1 - Extended Throughput, enabling processing of up to 500,000 cells per run under an instrument free workflow. This release significantly enhances scaling, multiplexing, and cost efficiency in transcriptomic studies.
In May 2024, Bruker Corporation, a US-based manufacturer of scientific instruments, acquired NanoString Technologies for approximately $392.6 million. This acquisition aims to integrate NanoString's gene expression profiling and spatial transcriptomics solutions into Bruker's expanding spatial biology portfolio. The integration of NanoString's technology will enhance Bruker's capabilities in discovery and translational research, positioning them as a leader in single-cell and spatial biology innovations.
Major companies operating in the single-cell analysis transcriptomics market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius Aktiengesellschaft, Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Abcam Limited, Novogene Co. Ltd., Standard BioTools Inc., Akoya Biosciences Inc., Parse Biosciences Inc., Cell Microsystems Inc., Mission Bio Inc., CYTENA GmbH, Fluent BioSciences
North America was the largest region in the single-cell analysis transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the single-cell analysis transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The single-cell analysis transcriptomics market consists of revenues earned by entities by providing services such as data analysis and interpretation, sample preparation, and customized gene expression profiling solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The single-cell analysis transcriptomics market includes sales of RNA extraction kits, library preparation kits, cnd DNA synthesis kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Single-Cell Analysis Transcriptomics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses single-cell analysis transcriptomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for single-cell analysis transcriptomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single-cell analysis transcriptomics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.